CSS »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by CSS

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by CSS from 13F filings

Historical chart of CSS investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by CSS

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 2.4M 0.99

More positions owned by CSS

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
American Airlines Group Note 6.500% 7/0 (Principal)
Microstrategy Cl A New (MSTR)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Ark Etf Tr Innovation Etf (ARKK)
Ionis Pharmaceuticals Note 4/0 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)
Ncl Corp Note 5.375% 8/0 (Principal)
American Airls (AAL)
Zscaler Note 0.125% 7/0 (Principal)
Microstrategy Note 2/1 (Principal)
Bentley Sys Note 0.125% 1/1 (Principal)
Spdr Gold Tr Gold Shs (GLD)

View all positions for CSS

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Calamos Advisors
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1